Legend Biotech (LEGN) News Today $34.00 -0.89 (-2.55%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$34.29 +0.29 (+0.84%) As of 06/20/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LEGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Shares Sold by Matthews International Capital Management LLCMatthews International Capital Management LLC lowered its stake in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 7.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,101,June 19, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Down - Here's What HappenedLegend Biotech (NASDAQ:LEGN) Shares Gap Down - Time to Sell?June 17, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Price Down 3.5% - Time to Sell?Legend Biotech (NASDAQ:LEGN) Shares Down 3.5% - Here's What HappenedJune 16, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Short Interest UpdateLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 12,840,000 shares, a growth of 69.4% from the May 15th total of 7,580,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the short-interest ratio is currently 7.8 days. Currently, 7.0% of the company's stock are sold short.June 15, 2025 | marketbeat.comABS Direct Equity Fund LLC Invests $1.12 Million in Legend Biotech Co. (NASDAQ:LEGN)ABS Direct Equity Fund LLC purchased a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 33,100 shares of the company's stock, valued at approximately $1,123,000. Legend Biotech makJune 15, 2025 | marketbeat.comGAMMA Investing LLC Buys 43,278 Shares of Legend Biotech Co. (NASDAQ:LEGN)GAMMA Investing LLC raised its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 8,227.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 43,804 shares of the company's stock after acquiring an additional 4June 15, 2025 | marketbeat.comSG Americas Securities LLC Buys 108,509 Shares of Legend Biotech Co. (NASDAQ:LEGN)SG Americas Securities LLC boosted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 661.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 124,926 shares of the company's stock aftJune 14, 2025 | marketbeat.comHarbor Capital Advisors Inc. Acquires 33,096 Shares of Legend Biotech Co. (NASDAQ:LEGN)Harbor Capital Advisors Inc. boosted its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 513.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,537 shares of the companyJune 13, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Trading 7.6% Higher - Time to Buy?Legend Biotech (NASDAQ:LEGN) Trading Up 7.6% - Still a Buy?June 10, 2025 | marketbeat.comCantor Fitzgerald Weighs in on Legend Biotech FY2026 EarningsLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Legend Biotech in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst R. Bienkowski forecasts that the company will post earnings pJune 10, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Receives Average Recommendation of "Moderate Buy" from AnalystsLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven ratings firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to tJune 8, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Time to Buy?Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Time to Buy?June 5, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Up 6.7% - Here's What HappenedLegend Biotech (NASDAQ:LEGN) Shares Up 6.7% - What's Next?June 4, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 23,847 Legend Biotech Co. (NASDAQ:LEGN)Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 23,847 shares of the company's sJune 4, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 36,181 Shares of Legend Biotech Co. (NASDAQ:LEGN)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 36.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,438 sharesJune 4, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Trading Down 3.8% - Time to Sell?Legend Biotech (NASDAQ:LEGN) Stock Price Down 3.8% - Time to Sell?June 3, 2025 | marketbeat.comLegend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual MeetingJune 3, 2025 | globenewswire.comLansforsakringar Fondforvaltning AB publ Takes Position in Legend Biotech Co. (NASDAQ:LEGN)Lansforsakringar Fondforvaltning AB publ purchased a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 28,093 shares of theMay 31, 2025 | marketbeat.comWellington Management Group LLP Buys 84,405 Shares of Legend Biotech Co. (NASDAQ:LEGN)Wellington Management Group LLP boosted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,120,775 shares of the companyMay 30, 2025 | marketbeat.comPolar Asset Management Partners Inc. Increases Holdings in Legend Biotech Co. (NASDAQ:LEGN)Polar Asset Management Partners Inc. grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 65.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,638 shares of the company's stock after buyingMay 29, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Squarepoint Ops LLCSquarepoint Ops LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 44.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,900 shares of the company's stock after acquiring an additional 39,197May 28, 2025 | marketbeat.comWoodline Partners LP Boosts Holdings in Legend Biotech Co. (NASDAQ:LEGN)Woodline Partners LP raised its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 10.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 120,304 shares of the company's stock after purchasing an additional 10,909 shares durMay 27, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by Millennium Management LLCMillennium Management LLC reduced its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 55.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 255,468 shares of the company's stMay 27, 2025 | marketbeat.comTwo Sigma Advisers LP Raises Position in Legend Biotech Co. (NASDAQ:LEGN)Two Sigma Advisers LP boosted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 904.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 327,400 shares of the company's stock after buying an additional 294,800May 25, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Stock Position Lifted by Twinbeech Capital LPTwinbeech Capital LP grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 132.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 73,168 shares of the company's stock after purchasing an additional 41,710 shares duringMay 24, 2025 | marketbeat.comTwo Sigma Investments LP Acquires 581,952 Shares of Legend Biotech Co. (NASDAQ:LEGN)Two Sigma Investments LP increased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 961.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 642,452 shares of the company's stock after purchasing an additional 581,952 shaMay 24, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Still a Buy?Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's What HappenedMay 23, 2025 | marketbeat.comLegend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCTMay 22, 2025 | globenewswire.comDeutsche Bank AG Boosts Stake in Legend Biotech Co. (NASDAQ:LEGN)Deutsche Bank AG increased its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 11.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,067 shares of the cMay 22, 2025 | marketbeat.comVestal Point Capital LP Has $15.46 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Vestal Point Capital LP increased its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 280.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 475,000 shares of the company's stock afMay 21, 2025 | marketbeat.comTema Etfs LLC Makes New $370,000 Investment in Legend Biotech Co. (NASDAQ:LEGN)Tema Etfs LLC purchased a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,362 shares of the company'sMay 21, 2025 | marketbeat.comBank of America Corp DE Buys 467,386 Shares of Legend Biotech Co. (NASDAQ:LEGN)Bank of America Corp DE grew its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 192.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 710,626 shares of the company's stock after acMay 21, 2025 | marketbeat.comTiger Pacific Capital LP Buys 53,100 Shares of Legend Biotech Co. (NASDAQ:LEGN)Tiger Pacific Capital LP grew its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 31.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 222,000 shares of the company's stock after aMay 20, 2025 | marketbeat.comTang Capital Management LLC Makes New $14.64 Million Investment in Legend Biotech Co. (NASDAQ:LEGN)Tang Capital Management LLC acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 450,000 shares of the company's stoMay 20, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Position Increased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 65.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 24,638 shares of the company's stock after purchasing an additional 9,779May 20, 2025 | marketbeat.comNorthern Trust Corp Has $9.26 Million Position in Legend Biotech Co. (NASDAQ:LEGN)Northern Trust Corp grew its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 239.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 284,678 shares of the company's stock after buying an additional 200,May 20, 2025 | marketbeat.comQ2 EPS Estimates for Legend Biotech Lifted by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at HC Wainwright boosted their Q2 2025 earnings estimates for Legend Biotech in a research note issued on Wednesday, May 14th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of $0.3May 20, 2025 | marketbeat.comLegend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual MeetingMay 19, 2025 | finance.yahoo.comSuvretta Capital Management LLC Invests $113.77 Million in Legend Biotech Co. (NASDAQ:LEGN)Suvretta Capital Management LLC purchased a new stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,496,234 shares of the company's stock,May 19, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by Polar Capital Holdings PlcPolar Capital Holdings Plc trimmed its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 23.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 381,873 shares of the company's stock after selling 11May 18, 2025 | marketbeat.comAmeriprise Financial Inc. Has $24.94 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)Ameriprise Financial Inc. raised its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 766,440 shares of the company's stock afMay 17, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Hits New 52-Week Low on Analyst DowngradeLegend Biotech (NASDAQ:LEGN) Hits New 12-Month Low After Analyst DowngradeMay 17, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by LMR Partners LLPLMR Partners LLP decreased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 46.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,200 shares of the company's stock after selling 57,20May 16, 2025 | marketbeat.comJanus Henderson Group PLC Has $70.20 Million Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)Janus Henderson Group PLC trimmed its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,156,749 shares of the company's stocMay 16, 2025 | marketbeat.comWilliam Blair Reaffirms Their Hold Rating on Legend Biotech (LEGN)May 15, 2025 | theglobeandmail.comHudson Bay Capital Management LP Invests $6.59 Million in Legend Biotech Co. (NASDAQ:LEGN)Hudson Bay Capital Management LP bought a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 202,500 shares of the company's stock, valued at appMay 14, 2025 | marketbeat.comLegend Biotech Corp (LEGN) Q1 2025 Earnings Call Highlights: Record Growth in CARVYKTI Sales ...May 14, 2025 | finance.yahoo.comBNP Paribas Financial Markets Invests $7.94 Million in Legend Biotech Co. (NASDAQ:LEGN)BNP Paribas Financial Markets acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 243,989 shares of the company's stock, vMay 14, 2025 | marketbeat.comLegend Biotech Corporation (LEGN) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comLegend Biotech Corporation 2025 Q1 - Results - Earnings Call PresentationMay 13, 2025 | seekingalpha.com Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address LEGN Media Mentions By Week LEGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼1.440.67▲Average Medical News Sentiment LEGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼36▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News TEVA News SMMT News GMAB News ITCI News RDY News ASND News VTRS News QGEN News MRNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LEGN Stock Free LEGN Stock Alerts